CSIMarket
 


Liquidia Corporation  (LQDA)
Other Ticker:  
 
 

LQDA's Revenue Growth by Quarter and Year

Liquidia's Revenue results by quarter and year




LQDA Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 4.53 5.36 3.22
III Quarter September - 3.68 3.17 3.18
II Quarter June - 4.79 3.92 3.38
I Quarter March 2.97 4.49 3.49 3.08
FY   2.97 17.49 15.94 12.86



LQDA Revenue first quarter 2024 Y/Y Growth Comment
Liquidia Corporation reported fall in Revenue in the first quarter 2024 by -33.81% to $ 2.97 millions, from the same quarter in 2023.
The drop in the first quarter 2024 Liquidia Corporation's Revenue compares unfavorably to the Company's average Revenue rise of 21.48%.

Looking into first quarter 2024 results within Major Pharmaceutical Preparations industry 74 other companies have achieved higher Revenue growth. While Liquidia Corporation' s Revenue drop of -33.81% ranks overall at the positon no. 1059 in the first quarter 2024.




LQDA Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - -15.49 % 66.46 % 335.14 %
III Quarter September - 16.09 % -0.31 % -
II Quarter June - 22.19 % 15.98 % -
I Quarter March -33.81 % 28.65 % 13.31 % -
FY   - 9.72 % 23.95 % 1637.84 %

Financial Statements
Liquidia's first quarter 2024 Revenue $ 2.97 millions LQDA's Income Statement
Liquidia's first quarter 2023 Revenue $ 4.49 millions Quarterly LQDA's Income Statement
New: More LQDA's historic Revenue Growth >>


LQDA Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 23.1 % 69.09 % 1.26 %
III Quarter September - -23.17 % -19.13 % -5.92 %
II Quarter June - 6.68 % 12.32 % 9.74 %
I Quarter March -34.39 % -16.23 % 8.39 % 316.22 %
FY (Year on Year)   - 9.72 % 23.95 % 1637.84 %




Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #75
Healthcare Sector #201
Overall #1059

Revenue Y/Y Growth Statistics
High Average Low
32.88 % 21.48 % -5.72 %
(Sep 30 2022)   (Mar 31 2024)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #75
Healthcare Sector #201
Overall #1059
Revenue Y/Y Growth Statistics
High Average Low
32.88 % 21.48 % -5.72 %
(Sep 30 2022)   (Mar 31 2024)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Liquidia's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
316.92 % 17.76 % -100 %
(Mar 31 2021)  


LQDA's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Liquidia Corporation reported fall in Revenue sequentially by -34.39% to $ 2.97 millions, from $ 4.53 millions declared a quarter before.

If you look into present shortcoming in the I. Quarter 2024, you suppose to assume, that commonly I. Quarter performance occur sluggish then in the preciding period, Dahnya González, Major Pharmaceutical Preparations industry researcher said.

Within Major Pharmaceutical Preparations industry 119 other companies have achieved higher Revenue quarter on quarter growth. While Liquidia's Revenue growth quarter on quarter, overall rank is 2499.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #120
Healthcare Sector #335
Overall #2499
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #120
Healthcare Sector #335
Overall #2499
Revenue Q/Q Growth Statistics
High Average Low
316.92 % 17.76 % -100 %
(Mar 31 2021)  


LQDA's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Liquidia Corporation disclosed fall in Revenue sequentially by -34.39% to $ 2.97 millions, from $ 4.53 millions declared a quarter before.

This is not important issue, as Liquidia's Revenue frequently tend to plunge in this quarter Dahnya González, Major Pharmaceutical Preparations industry researcher wrote.

Within Major Pharmaceutical Preparations industry 119 other companies have achieved higher Revenue quarter on quarter growth. While Liquidia's Revenue growth quarter on quarter, overall rank is 2499.


Liquidia's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 15.97 $ 17.49 $ 18.32 $ 17.80 $ 16.94
Y / Y Revenue Growth (TTM) -5.72 % 9.75 % 32.83 % 28.98 % 27.71 %
Year on Year Revenue Growth Overall Ranking # 330 # 543 # 207 # 457 # 651
Seqeuential Revenue Change (TTM) -8.7 % -4.53 % 2.88 % 5.13 % 6.28 %
Seq. Revenue Growth (TTM) Overall Ranking # 1059 # 801 # 2214 # 1654 # 2112




Cumulative Revenue growth Comment
For the 12 months ended Mar 31 2024 Liquidia reported a decrease in Revenue by -5.72% year on year, to $16 millions, compare to the 9.75% growth at Dec 31 2023.

In the Healthcare sector 83 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 330, from total ranking in previous quarter at 543.

Revenue TTM Q/Q Growth Statistics
High Average Low
32.88 %
21.48 %
-5.72 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 75
Healthcare Sector # 84
Overall # 330

Revenue TTM Y/Y Growth Statistics
High Average Low
32.88 %
21.48 %
-5.72 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 75
Sector # 201
S&P 500 # 1059
Cumulative Revenue growth Comment
For the 12 months ended Mar 31 2024 Liquidia reported a decrease in Revenue by -5.72% year on year, to $16 millions, compare to the 9.75% growth at Dec 31 2023.

In the Healthcare sector 83 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 330, from total ranking in previous quarter at 543.

Revenue TTM Q/Q Growth Statistics
High Average Low
32.88 %
21.48 %
-5.72 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 75
Healthcare Sector # 84
Overall # 330

Revenue TTM Y/Y Growth Statistics
High Average Low
32.88 %
21.48 %
-5.72 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 75
Sector # 201
S&P 500 # 1059




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LQDA's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LQDA's Competitors
Revenue Growth for Liquidia's Suppliers
Revenue Growth for LQDA's Customers

You may also want to know
LQDA's Annual Growth Rates LQDA's Profitability Ratios LQDA's Asset Turnover Ratio LQDA's Dividend Growth
LQDA's Roe LQDA's Valuation Ratios LQDA's Financial Strength Ratios LQDA's Dividend Payout Ratio
LQDA's Roa LQDA's Inventory Turnover Ratio LQDA's Growth Rates LQDA's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Collegium Pharmaceutical inc -0.21%$ -0.215 millions
Mettler Toledo International Inc-0.30%$ -0.300 millions
3m Company-0.35%$ -0.349 millions
Icu Medical Inc-0.42%$ -0.423 millions
Lifeloc Technologies Inc -0.51%$ -0.513 millions
Regeneron Pharmaceuticals Inc -0.54%$ -0.541 millions
Envista Holdings Corporation-0.62%$ -0.622 millions
Orgenesis Inc -0.70%$ -0.704 millions
Vyne Therapeutics Inc -1.01%$ -1.010 millions
Ge Healthcare Technologies Inc -1.50%$ -1.502 millions
Baxter International Inc -1.56%$ -1.562 millions
Y mabs Therapeutics inc -1.58%$ -1.580 millions
Pacific Biosciences Of California Inc -1.59%$ -1.589 millions
Cartesian Therapeutics Inc -1.65%$ -1.650 millions
Viatris Inc -1.76%$ -1.762 millions
Ocuphire Pharma Inc -2.17%$ -2.173 millions
Vaso Corporation-2.51%$ -2.513 millions
Dentsply Sirona Inc -2.56%$ -2.556 millions
Alpha Pro Tech Ltd -2.78%$ -2.775 millions
Prestige Consumer Healthcare Inc -2.82%$ -2.817 millions
West Pharmaceutical Services Inc -2.99%$ -2.986 millions
Integra Lifesciences Holdings Corp-3.14%$ -3.144 millions
Accelerate Diagnostics Inc -3.17%$ -3.165 millions
National Research Corporation-3.18%$ -3.180 millions
Catheter Precision Inc -3.53%$ -3.529 millions
Elanco Animal Health Inc-4.14%$ -4.137 millions
Ptc Therapeutics inc -4.66%$ -4.657 millions
Foghorn Therapeutics Inc -4.88%$ -4.879 millions
Aclaris Therapeutics Inc -5.14%$ -5.142 millions
Avantor Inc -5.65%$ -5.645 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com